OTCMKTS:IMUC EOM Pharmaceutical (IMUC) Stock Price, News & Analysis $0.05 -0.02 (-24.93%) As of 03:32 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChart About EOM Pharmaceutical Stock (OTCMKTS:IMUC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EOM Pharmaceutical alerts:Sign Up Key Stats Today's Range$0.05▼$0.0550-Day Range$0.07▼$0.2052-Week Range$0.02▼$0.27Volume9,649 shsAverage Volume6,512 shsMarket Capitalization$6.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview EOM Pharmaceutical is a pharmaceutical and biotechnology company associated with the OTC Markets symbol IMUC. Publicly available information about the company’s current operations, product portfolio and commercial markets is limited, so a detailed description of its present business is not readily available. Historical records indicate that the symbol was previously associated with ImmunoCellular Therapeutics, a biotechnology company focused on developing cancer immunotherapies. Its lead program, ICT-107, was an investigational dendritic-cell vaccine designed to target glioblastoma, an aggressive form of brain cancer. ImmunoCellular Therapeutics evaluated ICT-107 in clinical trials but later discontinued development following unsuccessful late-stage results. The company subsequently adopted the EOM Pharmaceutical name; however, reliable public information describing its current leadership, products, geographic reach or operating activities is limited.AI Generated. May Contain Errors. Read More Receive IMUC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EOM Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMUC Stock News HeadlinesEom Pharmaceutical Holdings Stock Price HistorySeptember 2, 2026 | investing.comEOM Pharmaceutical Holdings Inc (IMUC) Real-TimeMay 27, 2026 | nasdaq.comBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.November 3 at 1:00 AM | Decentralized Masters (Ad)Eom Pharmaceutical Holdings IncMay 27, 2026 | cnbc.comEOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer PatientsMay 27, 2026 | markets.businessinsider.comEOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147January 7, 2026 | tmcnet.comQ32 Bio Inc. R (DB0.BE)January 15, 2025 | finance.yahoo.comImmunoCellular Therapeutics, Ltd. (IMUC)January 5, 2024 | uk.finance.yahoo.comSee More Headlines IMUC Stock Analysis - Frequently Asked Questions How have IMUC shares performed this year? EOM Pharmaceutical's stock was trading at $0.0710 at the start of the year. Since then, IMUC stock has decreased by 27.9% and is now trading at $0.0512. How were EOM Pharmaceutical's earnings last quarter? EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC) issued its quarterly earnings data on Monday, August, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. How do I buy shares of EOM Pharmaceutical? Shares of IMUC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of EOM Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some other companies that EOM Pharmaceutical investors own include Inovio Pharmaceuticals (INO), OPKO Health (OPK), Celldex Therapeutics (CLDX), FuelCell Energy (FCEL), Gilead Sciences (gild), Plug Power (PLUG) and MannKind (MNKD). Company Calendar Last Earnings8/13/2018Today11/03/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:IMUC CIK822411 Webeompharma.com Phone(201) 351-0605Fax818-224-5287Employees3Year Founded2006Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares126,500,000Free Float122,354,000Market Cap$6.59 million OptionableNot Optionable Beta0.11 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:IMUC) was last updated on 11/3/2026 by MarketBeat.com Staff. From Our PartnersYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times th...Behind the Markets | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhat Elon Musk's Cybercab Reveal Could Mean for InvestorsJeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | SponsoredRobert Kiyosaki's Energy Income Plan Pays Out 74 Times a YearRobert Kiyosaki built his wealth on assets that pay every month, not once. His Perpetual Income Plan pools 15 ...Freedom Financial | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EOM Pharmaceutical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EOM Pharmaceutical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMUC Stock Alerts